Showing results (481-490 of 502) with videos related to

Sort By:
Pageof 51
Nature Immunology|October 5, 2019
Author Correction: Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockadeBrian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Nature Immunology|February 20, 2019
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockadeBrian C Miller, Debattama R Sen, Rose Al Abosy, et al.
Nature|September 24, 2025
In vivo CRISPR screens identify modifiers of CAR T cell function in myelomaNelson H Knudsen, Giulia Escobar, Felix Korell, et al.
Cancer Discovery|March 10, 2017
Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate ImmunityAkash Patnaik, Kenneth D Swanson, Eva Csizmadia, et al.
Cell|October 27, 2015
Engineering a therapeutic lectin by uncoupling mitogenicity from antiviral activityMichael D Swanson, Daniel M Boudreaux, Loïc Salmon, et al.
Nature|December 19, 2018
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockadeJeffrey J Ishizuka, Robert T Manguso, Collins K Cheruiyot, et al.
Neurology|November 6, 2015
ADCY5-related dyskinesia: Broader spectrum and genotype-phenotype correlationsDong-Hui Chen, Aurélie Méneret, Jennifer R Friedman, et al.
Nature|May 6, 2021
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicityGabriel K Griffin, Jingyi Wu, Arvin Iracheta-Vellve, et al.
Nature Communications|September 29, 2025
In vivo CRISPR screening in head and neck cancer reveals Uchl5 as an immunotherapy targetCong Fu, Robert Saddawi-Konefka, Jordan M Chinai, et al.
Pageof 51